VORICONAZOL ÎN TERAPIA INFECŢIILOR FUNGICE SEVERE

May 1, 2006

Carmen Dorobăț *, Cătălina Luca *, Carmen Manciuc *, M. Hurmuzache *, C. Dragoman *, Ch. Dorobăț **, Andra Teodor *, D. Teodor *, V Botoc **, E. Năstase *
* Carmen Dorobăț, Cătălina Luca, Carmen Manciuc, M. Hurmuzache, C. Dragoman, Andra Teodor, D. Teodor, E. Năstase – Clinica de Boli Infecțioase lași
** Dorobăț, V Botoc – Spitalul de Neurochirngie Iași

Abstract

The life of an increased number of immunocompromised patients are threatened by the spectrum of infection with pathogenic fungi. Some of them have intrinsec resistance to antifungal therapy and others become resistant during the treatment. For that, the management of systemic fungal infection today is a challenge for the practitioners. We reviewed the data regarding most common systemic fungal infection for wich antifungal resistance is a potential problem.